An Overview of Cell and Gene Therapies
An Overview of Cell and Gene Therapies Since 2017, four new cell and gene therapies have become available in the U.S. with prices ranging from $373,000 to $2.1 million for a one-time administration. Gene [...]
Two Labs Acquires CEEK Enterprises
At Two Labs, our mission is to improve patients’ quality of life by delivering innovative trade and commercialization services to pharmaceutical manufacturers. This is why we’re pleased to announce that as of February 3, 2020, Two Labs has acquired [...]
Two Labs a Best Place to Work in Central Ohio
Two Labs is proud to be named as one of Columbus Business First’s 2019 Best Places to Work in Central Ohio. The Best Places to Work program, which is now in its 15th year, invites companies with at [...]
Michael Rowe Joins Two Labs as DSCSA (Serialization) Compliance Services Manager
At Two Labs, we value partnership. We work hard to make sure our clients view us as an extended part of their team, and not just another vendor. As the pharma market continues to evolve, we are excited to expand [...]
What manufacturers need to know about Minnesota House Bill 400
We recently notified our clients and partners of several regulatory changes that will affect manufacturers and wholesalers doing business in Minnesota. In May 2019, Minnesota Governor Tim Walz signed House Bill 400, which created an Opioid Stewardship Advisory [...]
New regulation requirements impacting your license
In the pharmaceutical industry, state licensing requirements can change at a moment’s notice. Though no central “hub” exists listing all licensing updates for each state, our team of experts works with state boards on a routine basis to [...]